InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by Schoenberg Mark, Directeur Médical. Director active across 1 companies, notably UroGen Pharma Ltd.. In total, 17 reports have been recorded. Total volume traded: €4k. The latest transaction was disclosed on 18 November 2021 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations17 total
500 shares
Ordinary Shares
SEC:0001437749-22-010701:0·
500 shares
Ordinary Shares
SEC:0001209191-22-006384·
500 shares
Ordinary Shares
SEC:0001209191-22-006384:0·
209 shares
Ordinary Shares
SEC:0001209191-22-005416·
209 shares
Ordinary Shares
SEC:0001209191-22-005416:0·
€1,851160 shares@ €11.57120.0001% mcap100.0% of flow
Ordinary Shares
SEC:0001209191-21-065756·
Ideal exit: 15 Aug 2022 (T+270)
€1,851160 shares@ €11.57120.0001% mcap50.0% of flow
Ordinary Shares
SEC:0001209191-21-065756:0·
Ideal exit: 15 Aug 2022 (T+270)
500 shares
Ordinary Shares
SEC:0001209191-21-062360·
500 shares
Ordinary Shares
SEC:0001209191-21-062360:0·
208 shares
Ordinary Shares
SEC:0001209191-21-061868·
208 shares
Ordinary Shares
SEC:0001209191-21-061868:0·
500 shares
Ordinary Shares
SEC:0001209191-21-049477·
500 shares
Ordinary Shares
SEC:0001209191-21-049477:0·
208 shares
Ordinary Shares
SEC:0001209191-21-048398·
208 shares
Ordinary Shares
SEC:0001209191-21-048398:0·
500 shares
Ordinary Shares
SEC:0001209191-21-029758·
500 shares
Ordinary Shares
SEC:0001209191-21-029758:0·
17 of 17 declarations
About Schoenberg Mark
Mark Schoenberg is an executive at UroGen Pharma Ltd.
